DJO Global said today it won FDA 510(k) clearance for the Compex Wireless USA electronic stimulation device and is launching it in the U.S. market.
The Compex Wireless USA is the 1st wireless muscle electrostim approved by the FDA, DJO Global said. The device targets specific muscle fibers that cannot be reached through tranditional workouts by sending electronic pulses that create involuntary muscle contractions.
“Wireless USA is taking wearable technology to the next level. This product brings 25 years of proven technologies and innovations to new heights to provide athletes with real results from this wearable device. Most importantly, Wireless USA is accessible and beneficial to athletes of all sports and fitness levels to maximize their workouts and achieve peak performance,” DJO Consumer president Toby Bost said in a press release.
The device is designed for athletic training to help build muscle, enhance blood circulation and hasten recovery, San Diego, Calif.-based DJO Global said.
“Compex has been a key tool to enhance my performance since I started training. It allows me to activate all my muscle fibers, dig deeper and ultimately get stronger for competition day. With the introduction of Wireless USA, I’m now able to have more freedom and increase the usage of NMES in my training,” 2014 CrossFit competitor Josh Bridges said in prepared remarks.
Earlier this month, DJO Global subsidiary Encore Medical closed on the purchase of Zimmer (NYSE:ZMH) and Biomet assets that the merging companies were unloading to satisfy U.S. anti-trust regulations. The acquisition included Biomet Cobalt bone cement, Optivac cement mixing accessories, the SoftPac pouch and Discovery elbow system for the U.S. marketplace